Abstract
Serum osmolality is the sum of the osmolalities of every single dissolved particle in the blood such as sodium and associated anions, potassium, glucose, and urea. Under normal conditions, serum sodium concentration is the major determinant of serum osmolality. Effective blood osmolality, so-called blood tonicity, is created by the endogenous (e.g., sodium and glucose) and exogenous (e.g., mannitol) solutes that are capable of creating an osmotic gradient across the membranes. In case of change in effective blood osmolality, water shifts from the compartment with low osmolality into the compartment with high osmolarity in order to restore serum osmolality. The difference between measured osmolality and calculated osmolarity forms the osmolal gap. An increase in serum osmolal gap can stem from the presence of solutes that are not included in the osmolarity calculation, such as hypertonic treatments or toxic alcoholic ingestions. In clinical practice, determination of serum osmolality and osmolal gap is important in the diagnosis of disorders related to sodium, glucose and water balance, kidney diseases, and small molecule poisonings. As blood hypertonicity exerts its main effects on the brain cells, neurologic symptoms varying from mild neurologic signs and symptoms to life-threatening outcomes such as convulsions or even death may occur. Therefore, hypertonic states should be promptly diagnosed and cautiously managed. In this review, the causes and treatment strategies of hyperosmolar conditions including hypernatremia, diabetic ketoacidosis, hyperglycemic hyperosmolar syndrome, hypertonic treatments, or intoxications are discussed in detail to increase awareness of this important topic with significant clinical consequences.
Similar content being viewed by others
References
Argyropoulos C, Rondon-Berrios H, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan Z, Murata GH, Shapiro JI, Tzamaloukas AH (2016) Hypertonicity: pathophysiologic concept and experimental studies. Cureus 8(5):e596. https://doi.org/10.7759/cureus.596
Star RA (1990) Hyperosmolar states. Am J Med Sci 300:402–412. https://doi.org/10.1097/00000441-199012000-00012
Griveas I, Gompou A, Kyritsis I, Papatheodorou G, Agroyannis I, Tsakoniatis M, Kapeleris E, Vrachnes S (2012) Osmolal gap in hemodialyzed uremic patients. Artif Organs 36:16–20. https://doi.org/10.1111/j.1525-1594.2011.01293.x
Najem O, Shah MM, De Jesus O (2022) Serum osmolality. In: StatPearls [Internet]. Treasure Island, FL, StatPearls Publishing
Rondon-Berrios H, Argyropoulos C, Ing TS, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan ZJ, Murata GH, Shapiro JI, Tzamaloukas AH (2017) Hypertonicity: clinical entities, manifestations and treatment. World J Nephrol 6:1–13. https://doi.org/10.5527/wjn.v6.i1.1
Kruse JA, Cadnapaphornchai P (1994) The serum osmole gap. J Crit Care 9:185–197. https://doi.org/10.1016/0883-9441(94)90015-9
Fazekas AS, Funk GC, Klobassa DS, Rüther H, Ziegler I, Zander R, Semmelrock HJ (2013) Evaluation of 36 formulas for calculating plasma osmolality. Intensive Care Med 39:302–308. https://doi.org/10.1007/s00134-012-2691-0
Gennari FJ (1984) Current concepts. Serum osmolality. Uses and limitations. N Engl J Med 310:102–105. https://doi.org/10.1056/NEJM198401123100207
Blum J, Mehler PS (2007) Hyperglycemic hyperosmolar syndrome. In: Parsons PE, Wiener-Kronish JP (eds) Critical Care Secrets, 4th edn. Mosby Elsevier, Philadelphia, pp 323–327
Kraut JA, Kurtz I (2008) Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol 3:208–225. https://doi.org/10.2215/CJN.03220807
Smithline N, Gardner KD Jr (1976) Gaps–anionic and osmolal. JAMA 236:1594–1597. https://doi.org/10.1001/jama.236.14.1594
Madden N, Trachtman H (2016) Physiology of the developing kidney: sodium and water homeostasis and its disorders. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL (eds) Pediatric Nephrology, 7th edn. Springer-Verlag, Berlin and Heidelberg, pp 181–217
Bhave G, Neilson EG (2011) Body fluid dynamics: back to the future. J Am Soc Nephrol 22:2166–2181. https://doi.org/10.1681/ASN.2011080865
Seay NW, Lehrich RW, Greenberg A (2020) Diagnosis and management of disorders of body tonicity-hyponatremia and hypernatremia: core curriculum. Am J Kidney Dis 75:272–286. https://doi.org/10.1053/j.ajkd.2019.07.014
Bianchetti MG, Simonetti GD, Lava SAG, Bettinelli A (2016) Differential diagnosis and management of fluid, electrolyte and acid-base disorders. In: Geary DF, Schaefer F (eds) Pediatric Kidney Disease, 2nd edn. Springer-Verlag, Berlin, pp 825–881
Ackerman GL (1990) Serum sodium. In: Walker HK, Hall WD, Hurst JW (eds) Clinical methods: the history, physical, and laboratory examinations, 3rd edn. Butterworths, Boston, Chapter 194
Dennen P, Linas SL (2014) Hypernatremia. In: Gilbert SJ, Weiner DE, Gipson DS, Perazella MA, Tonelli M (eds) National Kidney Foundation Primer on Kidney Diseases, 6th edn. Elsevier Saunders, Philadelphia, pp 71–79
Jéquier E, Constant F (2010) Water as an essential nutrient: the physiological basis of hydration. Eur J Clin Nutr 64:115–123. https://doi.org/10.1038/ejcn.2009.111
Bonventre JV, Leaf A (1982) Sodium homeostasis: steady states without a set point. Kidney Int 21:880–883. https://doi.org/10.1038/ki.1982.113
Shaikh G, Sehgal R, Sandhu S, Vaddineni S, Fogel J, Rubinstein S (2014) Changes in osmol gap in chronic kidney disease: an exploratory study. Ren Fail 36:198–201. https://doi.org/10.3109/0886022X.2013.838052
Oostvogels R, Kemperman H, Hubeek I, ter Braak EWMT (2013) The importance of the osmolality gap in ethylene glycol intoxication. BMJ 347:f6904. https://doi.org/10.1136/bmj.f6904
Atluri P, Vasireddy D, Malayala SV (2021) Toxic alcohol ingestion: a case report and review of management pathways. Cureus 13(2):e13092. https://doi.org/10.7759/cureus.13092
Weissenborn K, Lockwood AH (2016) Toxic and metabolic encephalopathies. In: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL (eds) Bradley’s Neurology in Clinical Practice, 7th edn. Elsevier, London, pp 1209–1225
Wilson MMG (2007) Thirst and hydration. In: Birren JE (ed) Encyclopedia of Gerontology, 2nd edn. Academic Press, Oxford and San Diego, pp 630–634
Latcha S, Lubetzky M, Weinstein AM (2011) Severe hyperosmolarity and hypernatremia in an adipsic young woman. Clin Nephrol 76:407–411. https://doi.org/10.5414/cn106617
Goff DA, Higinio V (2009) Hypernatremia. Pediatr Rev 30:412–413. https://doi.org/10.1542/pir.30-10-412
Kumbar L, Yusufani R (2021) Hypernatremia. In: Ferri FF (ed) Ferri’s Clinical Advisor. Elsevier, Philadelphia, pp 732–734
Allison SP (2003) Dehydration. In: Caballero B (ed) Encyclopedia of Food Sciences and Nutrition, 2nd edn. Academic Press, Cambridge, MA, pp 1740–1743. https://doi.org/10.1016/B0-12-227055-X/00323-0
Kamel KS, Halperin ML (2017) Sodium and water physiology. In: Kamel KS, Halperin ML (eds) Fluid, electrolyte and acid-base physiology, 5th edn. Elsevier, Philadelphia, pp 216–263
Kim SW (2006) Hypernatemia: successful treatment. Electrolyte Blood Press 4:66–71. https://doi.org/10.5049/EBP.2006.4.2.66
Blohm E, Goldberg A, Salerno A, Jenny C, Boyer E, Babu K (2018) Recognition and management of pediatric salt toxicity. Pediatr Emerg Care 34:820–824. https://doi.org/10.1097/PEC.0000000000001340
Leung C, Chang WC, Yeh SJ (2009) Hypernatremic dehydration due to concentrated infant formula: report of two cases. Pediatr Neonatol 50:70–73. https://doi.org/10.1016/S1875-9572(09)60036-X
Liamis G, Liberopoulos E, Barkas F, Elisaf M (2014) Diabetes mellitus and electrolyte disorders. World J Clin Cases 2:488–496. https://doi.org/10.12998/wjcc.v2.i10.488
Popli S, Tzamaloukas AH, Ing TS (2014) Osmotic diuresis-induced hypernatremia: better explained by solute-free water clearance or electrolyte-free water clearance? Int Urol Nephrol 46:207–210. https://doi.org/10.1007/s11255-012-0353-3
Agrawal S, Baird GL, Quintos JB, Reinert SE, Gopalakrishnan G, Boney CM, Topor LS (2018) Pediatric diabetic ketoacidosis with hyperosmolarity: clinical characteristics and outcomes. Endocr Pract 24:726–732. https://doi.org/10.4158/EP-2018-0120
Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, Sperling MA, Codner E (2018) ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 19(Suppl 27):155–177. https://doi.org/10.1111/pedi.12701
Rumph KW, Kaiser H, Gröne HJ, Trapp VE, Meinck HM, Goebel HH, Kunze E, Kreuzer H, Scheler F (1981) Myoglobinuric renal failure in hyperosmolar diabetic coma (author’s transl). Dtsch Med Wschr 106:708–711. https://doi.org/10.1055/s-2008-1070386
Annangi S, Nutalapati S, Naramala S, Yarra P, Bashir K (2020) Uremia preventing osmotic demyelination syndrome despite rapid hyponatremia correction. J Investig Med High Impact Case Rep 8:2324709620918095. https://doi.org/10.1177/2324709620918095
Hagstam KE, Lindergård B, Tibbling G (1969) Mannitol infusion in regular haemodialysis treatment for chronic renal insufficiency. Scand J Urol Nephrol 3:257–263. https://doi.org/10.3109/00365596909135413
Rodrigo F, Shideman J, McHugh R, Buselmeier T, Kjellstrand C (1977) Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med 86:554–561. https://doi.org/10.7326/0003-4819-86-5-554
Silver SM, Sterns RH, Halperin ML (1996) Brain swelling after dialysis: old urea or new osmoles? Am J Kidney Dis 28:1–13. https://doi.org/10.1016/s0272-6386(96)90124-9
Arieff AI, Massry SG, Barrientos A, Kleeman CR (1973) Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int 4:177–187. https://doi.org/10.1038/ki.1973.100
Dursun H, Noyan A, Cengiz N, Attila G, Buyukcelik M, Soran M, Seydaoglu G, Bayazit AK, Anarat A (2007) Changes in osmolal gap and osmolality in children with chronic and end-stage renal failure. Nephron Physiol 105:19–21. https://doi.org/10.1159/000097604
Lutters B, Koehler PJ, Wijdicks EF (2020) Worth their salt: one hundred years of hyperosmolar therapy. Eur Neurol 83:536–541. https://doi.org/10.1159/000510183
Peters NA, Farrell LB, Smith JP (2018) Hyperosmolar therapy for the treatment of cerebral edema. US Pharm 43:HS-8-HS-11
Prough DS, Johnson JC, Stump DA, Stullken EH, Poole GV Jr, Howard G (1986) Effects of hypertonic saline versus lactated Ringer’s solution on cerebral oxygen transport during resuscitation from hemorrhagic shock. J Neurosurg 64:627–632. https://doi.org/10.3171/jns.1986.64.4.0627
Kheirbek T, Pascual JL (2014) Hypertonic saline for the treatment of intracranial hypertension. Curr Neurol Neurosci Rep 14:482. https://doi.org/10.1007/s11910-014-0482-4
Diringer MN (2013) New trends in hyperosmolar therapy? Curr Opin Crit Care 19:77–82. https://doi.org/10.1097/MCC.0b013e32835eba30
Stein MR (2010) The new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulins. Postgrad Med 122:176–184. https://doi.org/10.3810/pgm.2010.09.2214
Bucher AM, De Cecco CN, Schoepf UJ, Meinel FG, Krazinski AW, Spearman JV, McQuiston AD, Wang R, Bucher J, Vogl TJ, Katzberg RW (2014) Is contrast medium osmolality a causal factor for contrast-induced nephropathy? Biomed Res Int 2014:931413. https://doi.org/10.1155/2014/931413
Andreucci M, Solomon R, Tasanarong A (2014) Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int 2014:741018. https://doi.org/10.1155/2014/741018
Laerum F (1987) Cytotoxic effects of six angiographic contrast media on human endothelium in culture. Acta Radiol 28:99–105
Verghese PS (2014) Contrast nephropathy in children. J Pediatr Intensive Care 3:45–52. https://doi.org/10.3233/PIC-14090
Glaser DS (1996) Utility of the serum osmol gap in the diagnosis of methanol or ethylene glycol ingestion. Ann Emerg Med 27:343–346. https://doi.org/10.1016/s0196-0644(96)70271-8
Greene HR, Krasowski MD (2019) Correlation of osmolal gap with measured concentrations of acetone, ethylene glycol, isopropanol, methanol, and propylene glycol in patients at an academic medical center. Toxicol Rep 7:81–88. https://doi.org/10.1016/j.toxrep.2019.12.005
Pizon AF, Brooks DE (2006) Hyperosmolality: another indication for hemodialysis following acute ethylene glycol poisoning. Clin Toxicol (Phila) 44:181–183. https://doi.org/10.1080/15563650500514582
Lee CS, Auld J (2015) Heart failure: a primer. Crit Care Nurs Clin North Am 27:413–425. https://doi.org/10.1016/j.cnc.2015.07.009
Pazmiño PA, Pazmiño BP (1993) Treatment of acute hypernatremia with hemodialysis. Am J Nephrol 13:260–265. https://doi.org/10.1159/000168630
Macaulay D, Watson M (1967) Hypernatraemia in infants as a cause of brain damage. Arch Dis Child 42:485–491. https://doi.org/10.1136/adc.42.225.485
Jha AA, Behera V, Jairam A, Baliga KV (2014) Osmotic demyelination syndrome in a normonatremic patient of chronic kidney disease. Indian J Crit Care Med 18:609–611. https://doi.org/10.4103/0972-5229.140153
Shen Y, Cheng X, Ying M, Chang HT, Zhang W (2017) Association between serum osmolarity and mortality in patients who are critically ill: a retrospective cohort study. BMJ Open 7(5):e015729. https://doi.org/10.1136/bmjopen-2016-015729
Nicholson T, Bennett K, Silke B (2012) Serum osmolarity as an outcome predictor in hospital emergency medical admissions. Eur J Intern Med 23:e39–e43. https://doi.org/10.1016/j.ejim.2011.06.014
Alshayeb HM, Showkat A, Babar F, Mangold T, Wall BM (2011) Severe hypernatremia correction rate and mortality in hospitalized patients. Am J Med Sci 341:356–360. https://doi.org/10.1097/MAJ.0b013e31820a3a90
Holtfreter B, Bandt C, Kuhn SO, Grunwald U, Lehmann C, Schütt C, Gründling M (2006) Serum osmolality and outcome in intensive care unit patients. Acta Anaesthesiol Scand 50:970–977. https://doi.org/10.1111/j.1399-6576.2006.01096.x
Rohla M, Freynhofer MK, Tentzeris I, Farhan S, Wojta J, Huber K, Weiss TW (2014) Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care 3:84–92. https://doi.org/10.1177/2048872613516018
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Answers:
1. c; 2. e; 3. b; 4. d
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Büyükkaragöz, B., Bakkaloğlu, S.A. Serum osmolality and hyperosmolar states. Pediatr Nephrol 38, 1013–1025 (2023). https://doi.org/10.1007/s00467-022-05668-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-022-05668-1